Lexpos News

/Lexpos News

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH)

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) DMRC reference number: DMRC- 39439934 Date issued: 14 May 2026 Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. Marketing Authorisation Holder: Fresenius Medical Care Deutschland GmbH [...]

The post MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) appeared first on Community Pharmacy England.

By |May 14th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH)

NMS myth busting series (#1)

    The post NMS myth busting series (#1) appeared first on Community Pharmacy England.

By |May 12th, 2026|Lexpos News|Comments Off on NMS myth busting series (#1)

We’re coming to a town near you

Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the first week of June. The series of interactive evening sessions will bring local pharmacies together with the people negotiating on their behalf to talk openly about funding, the challenges facing [...]

The post We’re coming to a town near you appeared first on Community Pharmacy England.

By |May 11th, 2026|Lexpos News|Comments Off on We’re coming to a town near you

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...]

The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.

By |May 11th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

IT system selection survey

NHS IT teams want to learn how community pharmacy owners and decision makers decide which services IT system to use or move towards when system decisions are being made. The aim would be to help pharmacy owners choose pharmacy IT systems and services (e.g. a Pharmacy First IT solution) more easily, in a clearer and [...]

The post IT system selection survey appeared first on Community Pharmacy England.

By |May 11th, 2026|Lexpos News|Comments Off on IT system selection survey